enGene Therapeutics Inc. (ENGN) insider trading
Over the last 12 months, 1 insider bought $10.1K and 0 insiders sold $0 of enGene Therapeutics Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Sep 22, 2026: Grossman William bought 5,102 shares ($10.1K)
- Oct 30, 2024: Forbion Growth Opportunities Fund I Cooperatief U.A. bought 561,797 shares ($5.00M)